No results found

Your search did not match any results.

We suggest you try the following to help find what you’re looking for:

  • Check the spelling of your keyword search.
  • Use synonyms for the keyword you typed, for example, try “application” instead of “software.”
  • Try one of the popular searches shown below.
  • Start a new search.
Trending Questions
Press Release

Oracle Buys Intellectual Property Assets of Conformia

Redwood Shores, Calif.—Jun 17, 2009

News Facts

  • Today Oracle announced that it has acquired the intellectual property assets of Conformia Software.
  • Conformia’s Product and Process Lifecycle Management (PPLM) software has unique capabilities for Life Sciences companies to manage drug design, development and transfer to production across Bio, Pharmaceutical and Chemical drug components.
  • Oracle plans to integrate Conformia’s product and technology into Oracle Agile PLM solution to offer an end-to-end solution for managing drug development, packaging and commercialization.
  • Oracle plans to provide integrations to Oracle applications, Oracle Health Sciences applications and 3rd party systems.
  • This combination will enable Pharmaceutical and Bio-technology companies to accelerate innovation, meet regulatory objectives and improve productivity.
  • Financial details of the transaction were not disclosed.
    • “The addition of Conformia Software technology underscores Oracle’s commitment to provide customers with a differentiated, out-of-box industry-based solution," said Oracle Vice President of PLM Strategy Hardeep Gulati. "Oracle’s PLM offering will give our Life Sciences industry customers a complete solution to manage drug design, development to commercialization.”

Contact Info
Susie Penner
Oracle Public Relations
Ken Bond
Oracle Investor Relations
About Oracle

Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NYSE:ORCL), visit


Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Talk to a Press Contact

Susie Penner

  • +1.650.506.1973

Ken Bond

  • +1.650.506.4073